Filing Details
- Accession Number:
- 0001127602-20-014027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-17 15:53:31
- Reporting Period:
- 2020-04-15
- Accepted Time:
- 2020-04-17 15:53:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1703647 | Frequency Therapeutics Inc. | FREQ | Pharmaceutical Preparations (2834) | 472324450 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1785288 | L. David Lucchino | C/O Frequency Therapeutics, Inc. 19 Presidential Way, 2Nd Floor Woburn MA 01801 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-04-15 | 5,236 | $15.13 | 459,992 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $14.73 to $15.465. The price reported in this column reflects the weighted average sales price.Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.